| 08 May, 07:49 pm | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange about Completion and Result of Postal Ballot dated 07 April 2026 | nse |
| 07 May, 06:30 pm | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Credit Rating | bse |
| 07 May, 06:30 pm | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange about Credit Rating | nse |
| 05 May, 11:24 pm | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 05 May, 11:16 pm | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript | nse |
| 27 Apr, 06:32 pm | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Investor Call Audio Recording | bse |
| 27 Apr, 05:59 pm | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange about Link of Recording | nse |
| 27 Apr, 06:32 am | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation | nse |
| 27 Apr, 06:32 am | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 27 Apr, 06:13 am | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated April 27, 2026, titled "Investor call to discuss the acquisition of Organon & Co.". | nse |
| 27 Apr, 06:11 am | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 27 Apr, 05:23 am | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange about Definitive Agreement to Acquire Organon | nse |
| 27 Apr, 05:15 am | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Acquisition | bse |
| 24 Apr, 01:23 pm | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange about Incorporation of a Subsidiary Company | nse |
| 17 Apr, 10:45 pm | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange regarding Completion and Results of Postal Ballot dated 17 March 2026 | nse |
| 10 Apr, 04:09 pm | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Rumour verification - Regulation 30(11) | bse |
| 10 Apr, 04:08 pm | — | … | The Exchange has sought clarification from Sun Pharmaceutical Industries Limited with respect to recent news item captioned Sun Pharma slips nearly 4% after $12 billion Organon deal enters final stage. The response from the Company is attached. | nse |
| 10 Apr, 11:11 am | — | … | The Exchange has sought clarification from Sun Pharmaceutical Industries Limited with respect to recent news item captioned Sun Pharma slips nearly 4% after $12 billion Organon deal enters final stage. The response from the Company is awaited. | nse |
| 04 Apr, 04:00 pm | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange regarding Appointment of Independent Director | nse |
| 04 Apr, 03:57 pm | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Change in Directorate | bse |
| 28 Mar, 12:27 am | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange about Updates on Fibromun and Nidlegy | nse |
| 27 Mar, 09:11 pm | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated March 27, 2026, titled "Sun Pharma Highlights Advances in Alopecia Areata, Psoriasis, and Acne Research at 2026 AAD Annual Meeting". | nse |
| 27 Mar, 09:11 pm | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 21 Mar, 11:57 am | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated March 21, 2026, titled "Sun Pharma launches its semaglutide injection under the brand names, Noveltreat and Sematrinity in India". | nse |
| 21 Mar, 08:35 am | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 17 Mar, 10:38 am | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange regarding 'Shareholder Satisfaction Survey on RTA Services'. | nse |
| 16 Mar, 04:23 pm | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated March 16, 2026, titled "Sun Pharma Announces US FDA Acceptance of Supplemental Biologics License (sBLA) Application for ILUMYA® (tildrakizumab-asmn) for the Treatment of Adults with Active Psoriatic Arthritis". | nse |
| 16 Mar, 04:23 pm | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 24 Feb, 03:45 pm | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 24 Feb, 03:42 pm | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation | nse |
| 04 Feb, 07:48 pm | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 04 Feb, 07:44 pm | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange about Transcript | nse |
| 02 Feb, 07:05 pm | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange regarding 'Sustainability Report for the financial year 2024-25'. | nse |
| 31 Jan, 08:22 pm | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange about Link of Recording | nse |
| 31 Jan, 08:21 pm | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Q3FY26 Earnings Call Audio Recording | bse |
| 31 Jan, 05:39 pm | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange regarding Change in Director(s) of the company. | nse |
| 31 Jan, 05:39 pm | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Change in Directorate | bse |
| 31 Jan, 02:35 pm | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange that Board of Directors at its meeting held on January 31, 2026, declared Interim Dividend of 11 per equity share. | nse |
| 31 Jan, 02:30 pm | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Corporate Action-Board approves Dividend | bse |
| 31 Jan, 02:28 pm | — | … | Sun Pharmaceutical Industries Limited has submitted to the Exchange the Unaudited Financial Results for the quarter and nine months ended 31 December 2025. | nse |
| 31 Jan, 02:26 pm | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Unaudited Financial Results For The Quarter And Nine Months Ended 31 December 2025 | bse |
| 23 Jan, 08:21 am | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated January 23, 2026, titled Sun Pharma receives DCGI approval to manufacture and market generic semaglutide injection in India for chronic weight management, . | nse |
| 23 Jan, 08:21 am | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 20 Jan, 06:59 pm | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange that the Record date for the purpose of the Interim Dividend for FY 2025-26 is 05 February 2026 | nse |
| 20 Jan, 06:48 pm | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Board Meeting Intimation for Approval Of Financial Results For The Quarter And Nine Months Ended 31 December 2025 And The Interim Dividend For FY 2025-26 | bse |
| 20 Jan, 12:39 pm | — | … | The Exchange has sought clarification from Sun Pharmaceutical Industries Limited with respect to recent news item captioned Sun Pharma Eyes Stronger US Presence With USD 10 Billion Organon Acquisition. The response from the Company is attached. | nse |
| 19 Jan, 12:46 pm | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Rumour verification - Regulation 30(11) | bse |
| 19 Jan, 11:14 am | — | … | The Exchange has sought clarification from Sun Pharmaceutical Industries Limited with respect to recent news item captioned Sun Pharma Eyes Stronger US Presence With USD 10 Billion Organon Acquisition. The response from the Company is awaited. | nse |
| 15 Jan, 10:57 pm | — | … | Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated January 15, 2026 | nse |
| 15 Jan, 10:52 pm | — | … | Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |